{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:54:26Z","timestamp":1777888466080,"version":"3.51.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2020,7,28]]},"DOI":"10.3233\/jpd-191833","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T11:56:17Z","timestamp":1586519777000},"page":"927-934","source":"Crossref","is-referenced-by-count":10,"title":["Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson\u2019s Disease: Pulsatile versus Continuous Dopaminergic Stimulation"],"prefix":"10.1177","volume":"10","author":[{"given":"Simone","family":"Simoni","sequence":"first","affiliation":[{"name":"Movement Disorders Center, Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico Paolini","family":"Paoletti","sequence":"additional","affiliation":[{"name":"Movement Disorders Center, Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"},{"name":"Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Eusebi","sequence":"additional","affiliation":[{"name":"Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Cappelletti","sequence":"additional","affiliation":[{"name":"Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Filidei","sequence":"additional","affiliation":[{"name":"Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elona","family":"Brahimi","sequence":"additional","affiliation":[{"name":"Neurology Department, Regina Montis Regalis Hospital, Cuneo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Nigro","sequence":"additional","affiliation":[{"name":"Movement Disorders Center, Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Santangelo","sequence":"additional","affiliation":[{"name":"Department of Philosophy, Social Sciences & Education, University of Perugia, Perugia, Italy"},{"name":"Neuroimaging Laboratory, IRCCS Santa Lucia Foundation, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[{"name":"Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"},{"name":"Section of Neurology Department, Center for Memory Disturbances, Laboratory of Clinical Neurochemistry, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[{"name":"Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"},{"name":"Dipartimento di Neuroscienze, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Tambasco","sequence":"additional","affiliation":[{"name":"Movement Disorders Center, Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"},{"name":"Neurology Department, Perugia General Hospital and University of Perugia, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-191833_ref1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","article-title":"Levodopa in Parkinson\u2019s disease: current status and future developments","volume":"16","author":"Tambasco","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JPD-191833_ref2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.07.010","article-title":"Dyskinesias and impulse control disorders in Parkinson\u2019s disease: from pathogenesis to potential therapeutic approaches","volume":"56","author":"Jim\u00e9nez-Urbieta","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JPD-191833_ref3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-018-0069-x","article-title":"Risk factors of levodopa-induced dyskinesia in Parkinson\u2019s disease: results from the PPMI cohort","volume":"4","author":"Eusebi","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"key":"10.3233\/JPD-191833_ref4","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"key":"10.3233\/JPD-191833_ref5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-191833_ref6","first-page":"429","article-title":"Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson\u2019s disease","volume":"260","author":"Kim","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.3233\/JPD-191833_ref7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case\u2014control study","volume":"69","author":"Voon","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-191833_ref8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson\u2019s disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-191833_ref9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS Clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord"},{"key":"10.3233\/JPD-191833_ref10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1741-7015-11-202","article-title":"DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions","volume":"11","author":"Nemeroff","year":"2013","journal-title":"BMC Med"},{"key":"10.3233\/JPD-191833_ref11","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the Unified Parkisnon\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric test resulting","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations the Movement disorder society task force on rating scales for Parkinson\u2019s disease","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/mds.870090403","article-title":"Utility of an objective dyskinesia rating scale for Parkinson\u2019s disease: inter- and intrarater reliability assessment","volume":"9","author":"Goetz","year":"1994","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease-Rating Scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref16","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.27181","article-title":"Impulse control disorders in advanced Parkinson\u2019s disease with dyskinesia: The ALTHEA study","volume":"32","author":"Biundo","year":"2017","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref17","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/ene.13078","article-title":"Impulse control disorder related behaviours during long-term rotigotine treatment: aanalysis","volume":"23","author":"Antonini","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.3233\/JPD-191833_ref18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/ene.13034","article-title":"A European multicentre survey of impulse control behaviours in Parkinson\u2019s disease patients treated with short- and long-acting dopamine agonists","volume":"23","author":"Rizos","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.3233\/JPD-191833_ref19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.psychres.2018.05.006","article-title":"Minnesota Impulse Disorders Interview (MIDI): Validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample","volume":"265","author":"Chamberlain","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.3233\/JPD-191833_ref20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02104901","article-title":"Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS)","volume":"10","author":"Shaffer","year":"1994","journal-title":"J Gambl Stud"},{"key":"10.3233\/JPD-191833_ref21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4088\/JCP.17m11612","article-title":"Prevalence of impulsive-compulsive symptoms in elderly Parkinson\u2019s disease patients: a case-control study","volume":"79","author":"Lo Monaco","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.3233\/JPD-191833_ref22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case\u2014control study","volume":"69","author":"Voon","year":"2011","journal-title":"Ann Neurol"},{"issue":"Pt 4","key":"10.3233\/JPD-191833_ref23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours","volume":"134","author":"O\u2019Sullivan","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JPD-191833_ref24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.25886","article-title":"Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease","volume":"29","author":"Vriend","year":"2014","journal-title":"Mov Disord"},{"issue":"Pt 12","key":"10.3233\/JPD-191833_ref25","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias","volume":"127","author":"de la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Brain"},{"key":"10.3233\/JPD-191833_ref26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-191833_ref27","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/mds.21118","article-title":"Punding and dyskinesias","volume":"21","author":"Silveira-Moriyama","year":"2006","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mds.26528","article-title":"Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson\u2019s disease patients","volume":"31","author":"Antonini","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.parkreldis.2015.07.020","article-title":"Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson\u2019s disease: Consensus from an international survey and discussion program","volume":"21","author":"Odin","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-191833_ref30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10072-016-2664-0","article-title":"Motor outcomes in patients with advanced Parkinson\u2019s disease treated with levodopa\/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study","volume":"37","author":"Lopiano","year":"2016","journal-title":"Neurol Sci"},{"key":"10.3233\/JPD-191833_ref31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jocn.2015.05.059","article-title":"Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson\u2019s disease","volume":"25","author":"Chang","year":"2016","journal-title":"J Clin Neurosci"},{"key":"10.3233\/JPD-191833_ref32","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/mds.25636","article-title":"Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson\u2019s disease","volume":"28","author":"Catal\u00e1n","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jnnp-2012-303988","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease: from clinical and neuropsychological characterisation to management and long-term outcome","volume":"85","author":"Cilia","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-191833_ref34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.26067","article-title":"EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson\u2019s disease","volume":"30","author":"Martinez-Martin","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-191833_ref35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00415-018-8803-1","article-title":"Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson\u2019s disease","volume":"265","author":"Catalan","year":"2018","journal-title":"J Neurol"},{"key":"10.3233\/JPD-191833_ref36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/WNF.0000000000000091","article-title":"Infusion therapies and development of impulse control disorders in advanced Parkinson disease: clinical experience after 3 years\u2019 follow-up","volume":"38","author":"Todorova","year":"2015","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-191833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:47:24Z","timestamp":1777610844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-191833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":36,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jpd-191833","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]}}}